These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38346844)

  • 1. Financial toxicity in gynecologic oncology: a multi-practice survey.
    Smith AJ; Sharma MH; Powell K; Doherty M; Hinkle SN; Ko EM
    Int J Gynecol Cancer; 2024 Jun; 34(6):919-925. PubMed ID: 38346844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crowdsourcing to measure financial toxicity in gynecologic oncology.
    Esselen KM; Stack-Dunnbier H; Gompers A; Hacker MR
    Gynecol Oncol; 2021 May; 161(2):595-600. PubMed ID: 33551197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial toxicity in gynecologic oncology.
    Bouberhan S; Shea M; Kennedy A; Erlinger A; Stack-Dunnbier H; Buss MK; Moss L; Nolan K; Awtrey C; Dalrymple JL; Garrett L; Liu FW; Hacker MR; Esselen KM
    Gynecol Oncol; 2019 Jul; 154(1):8-12. PubMed ID: 31053404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with increased financial toxicity after the completion of radiation treatment for gynecologic cancer.
    Esselen KM; Baig RA; Gompers A; Stack-Dunnbier H; Hacker MR; Jang JW
    Support Care Cancer; 2023 Jun; 31(7):388. PubMed ID: 37300721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial toxicity, mental health, and gynecologic cancer treatment: The effect of the COVID-19 pandemic among low-income women in New York City.
    Chen YS; Zhou ZN; Glynn SM; Frey MK; Balogun OD; Kanis M; Holcomb K; Gorelick C; Thomas C; Christos PJ; Chapman-Davis E
    Cancer; 2021 Jul; 127(14):2399-2408. PubMed ID: 33899220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial toxicity in patients with gynecologic malignancies: a cross sectional study.
    Zeybek B; Webster E; Pogosian N; Tymon-Rosario J; Balch A; Altwerger G; Clark M; Menderes G; Huang G; Azodi M; Ratner ES; Schwartz PE; Santin AD; Andikyan V
    J Gynecol Oncol; 2021 Nov; 32(6):e87. PubMed ID: 34431257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating meaningful levels of financial toxicity in gynecologic cancers.
    Esselen KM; Gompers A; Hacker MR; Bouberhan S; Shea M; Summerlin SS; Rucker LR; Huh WK; Pisu M; Liang MI
    Int J Gynecol Cancer; 2021 Jun; 31(6):801-806. PubMed ID: 33858954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive financial hardship among gynecologic cancer patients starting a new line of therapy.
    Liang MI; Pisu M; Summerlin SS; Boitano TKL; Blanchard CT; Bhatia S; Huh WK
    Gynecol Oncol; 2020 Feb; 156(2):271-277. PubMed ID: 31771866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insurance-based disparities and risk of financial toxicity among patients undergoing gynecologic cancer operations.
    Ng AP; Sanaiha Y; Verma A; Lee C; Akhavan A; Cohen JG; Benharash P
    Gynecol Oncol; 2022 Aug; 166(2):200-206. PubMed ID: 35660294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for financial toxicity in patients with gynecologic cancer.
    Aviki EM; Manning-Geist BL; Sokolowski SS; Newman T; Blinder VS; Chino F; Doyle SM; Liebhaber A; Gordhandas SB; Brown CL; Broach V; Chi DS; Jewell EL; Leitao MM; Long Roche K; Mueller JJ; Sonoda Y; Zivanovic O; Gardner GJ; Abu-Rustum NR
    Am J Obstet Gynecol; 2022 Jun; 226(6):817.e1-817.e9. PubMed ID: 34902319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between financial toxicity and health-related quality of life of patients with gynecologic cancer.
    Kajimoto Y; Honda K; Suzuki S; Mori M; Tsubouchi H; Nakao K; Azuma A; Shibutani T; Nagao S; Koyanagi T; Kohara I; Tamaki S; Yabuki M; Teng L; Fujiwara K; Igarashi A
    Int J Clin Oncol; 2023 Mar; 28(3):454-467. PubMed ID: 36648710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of employment and insurance status on distress in gynecologic oncology patients.
    Kuroki LM; Morris DH; Greenwade M; Landon M; Hagemann AR; Thaker PH; Massad LS; McCourt CK; Fuh KC; Powell MA; Mutch DG; Khabele D; Vanderlan JR
    Gynecol Oncol; 2021 May; 161(2):477-482. PubMed ID: 33546868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and financial toxicity in patients with renal cell carcinoma.
    Staehler MD; Battle DJ; Bergerot CD; Pal SK; Penson DF
    World J Urol; 2021 Jul; 39(7):2559-2565. PubMed ID: 33090258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment.
    Aviki EM; Thom B; Braxton K; Chi AJ; Manning-Geist B; Chino F; Brown CL; Abu-Rustum NR; Gany FM
    Support Care Cancer; 2022 Mar; 30(3):2713-2721. PubMed ID: 34822002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and ethnic disparities in palliative care utilization among gynecological cancer patients.
    Islam JY; Deveaux A; Previs RA; Akinyemiju T
    Gynecol Oncol; 2021 Feb; 160(2):469-476. PubMed ID: 33276985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of a financial navigation program in gynecologic oncology.
    Noor Chelsea N; Posever N; Hsieh TYJ; Patterson S; Sweeney C; Dalrymple JL; Dottino J; Wiechert AC; Garrett L; Hacker MR; Esselen KM
    Gynecol Oncol; 2024 Oct; 189():119-124. PubMed ID: 39096589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catastrophic health expenditures, insurance churn, and nonemployment among gynecologic cancer patients in the United States.
    Albright BB; Nitecki R; Chino F; Chino JP; Havrilesky LJ; Aviki EM; Moss HA
    Am J Obstet Gynecol; 2022 Mar; 226(3):384.e1-384.e13. PubMed ID: 34597606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study.
    Huntington SF; Weiss BM; Vogl DT; Cohen AD; Garfall AL; Mangan PA; Doshi JA; Stadtmauer EA
    Lancet Haematol; 2015 Oct; 2(10):e408-16. PubMed ID: 26686042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the Financial Toxicity of Radiation Oncology Patients Using the Validated Comprehensive Score for Financial Toxicity as a Patient-Reported Outcome.
    D'Rummo KA; Miller L; TenNapel MJ; Shen X
    Pract Radiat Oncol; 2020; 10(5):e322-e329. PubMed ID: 31634632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of the COmprehensive Score for financial Toxicity (COST) in patients with gynecologic cancer.
    Kajimoto Y; Shibutani T; Nagao S; Yamaguchi S; Suzuki S; Mori M; Tsubouchi H; Nakao K; Azuma A; Koyanagi T; Kohara I; Tamaki S; Yabuki M; Teng L; Honda K; Igarashi A
    Int J Gynecol Cancer; 2022 Apr; ():. PubMed ID: 35444012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.